Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Possible Mortality Imbalance For Shionogi's Cefiderocol On US FDA Panel Agenda
Oct 14 2019
•
By
Michael Cipriano
Shionogi's cUTI Candidate Cefiderocol Will Head To A US FDA Advisory Committee.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA Performance Tracker
More from Regulatory Trackers